Zhou, Jiawei
Cheng, Anqi
Guo, Jianqiang
Liu, Yafeng
Li, Xuan
Chen, Maoqian
Hu, Dong
Funding for this research was provided by:
Medical Special Cultivation Project of Anhui University of Science and Technology (YZ2023H1A006)
Clinical and Translational Research Project of Anhui Province (202427b10020102)
National Natural Science Foundation of China (81971483)
National Natural Science Foundation of China (81672445)
Article History
Received: 27 February 2025
Accepted: 28 March 2025
First Online: 11 April 2025
Declarations
:
: The ethics involving human tissues (tissue microarrays of triple-negative breast cancer (TNBC) patients) were approved by the Ethics Committee of Shanghai New Tide Biotechnology Co., Ltd. (approval No. SHYJS-CP-2210008). The ethics involving animals was approved by the medical ethics committee of Anhui University of Science and Technology (approval NO. HX-002).
: All the authors approved the publication.
: The authors declare that they have no competing interests.